134P Impact of pre-operative MammaPrint/BluePrint use for final treatment decisions in patients with stage II/IIIa HR+/HER2- early-stage breast cancer eligible for neoadjuvant chemotherapy: The DETERMIND study
| Autor: | Marin-Liebana, S., Morales, S., Torres, A. Anton, Iranzo, V., Zotano, A.L. Guerrero, Ponce, J., Adrover, E., Sanchez-Rovira, P., Martorell, A. Perello, Merino, L. de la Cruz, Borrego, M. Ruiz, Toral, J.C., Ayala de la Pena, F., Cussac, A. Llombart |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|